The Clinical and Laboratory Standards Institute (CLSI) released the latest guidance in antimicrobial susceptibility testing, breakpoints, and quality control. CLSI M02, M07, and M100 help to ensure accurate test results and better patient outcomes.
Some important changes to the new editions of CLSI M02 and CLSI M07 include:
Revised information for testing and reporting to clarify relevant stakeholders.
Revised nomenclature from “coagulase-negative staphylococci” (CoNS) to “staphylococci other than Staphylococcus aureus” (SOSA).
